Provider
QP83-23 Commercial Pharmacy Benefit Exclusion for Budesonide-Formoterol Aerosol Inhaler and Tiotropium Bromide Inhalation Capsule
Program effective Date: Oct 11, 2023
Program effective Date: Oct 11, 2023
Program effective Date: Oct 11, 2023
Program effective Date: Oct 11, 2023
Program effective Date: Oct 11, 2023
Program effective Date: Oct 11, 2023
Program effective Date: Oct 02, 2023
Program effective Date: Oct 02, 2023
Program effective Date: Oct 02, 2023
Program effective Date: Oct 02, 2023